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ABSTRACT 
 
Staphylococcus epidermidis is the most frequent cause of nosocomial sepsis and catheter-related infections, 
in which biofilm formation is considered to be the main virulence mechanism. In biofilm environment, 
microbes exhibit enhanced resistance to antimicrobial agents. This fact boosted the search of possible 
alternatives to antibiotics. Farnesol and N-acetylcysteine (NAC) are non-antibiotic drugs that have 
demonstrated antibacterial properties. In this study, the effect of farnesol and NAC isolated or in 
combination (farnesol+NAC) was evaluated. NAC at 10 × MIC caused a total cell death in planktonic cells. 
On the other hand, S. epidermidis biofilms exhibited 4 log reduction in viable cell number after a 24h 
treatment with NAC at the former concentration. Our results demonstrated that there was a higher CFU log 
reduction of S. epidermidis planktonic cells when farnesol was combined with NAC at 1 × MIC relatively to 
each agent alone. However, these results were not relevant because NAC alone at 10 × MIC was always the 
condition which gave the best results, having a very high killing effect on planktonic cells and a significant 
bactericidal effect on biofilm cells. This study demonstrated that no synergy was observed between farnesol 
and NAC. However, the pronounced antibacterial effect of NAC against S. epidermidis, on both lifestyles, 
indicates the use of NAC as a potential therapeutic agent in alternative to antibiotics. 
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INTRODUCTION 
 
Staphylococcus epidermidis lives naturally on the skin and 
mucous membrane as a commensal of the human skin flora (9) 
and was primarely considered a natural human inhabitant 
bacterium with a low pathogenic potential (22). However, in 
recent decades, this bacterium was identified as a common 
cause of numerous infections on indwelling medical devices 
(22) and actually S. epidermidis is among the most leading 
causes of nosocomial infections (16). These bacteria form 
biofilms on implanted medical devices such as central venous 
catheters (CVCs), urinary catheters, prosthetic heart valves, 
orthopedic devices, contact lenses, etc, and cause persistent 
infections (21) and diseases such as septicemia and 
endocarditis (3). The biofilm-forming ability of Staphylococcus 
epidermidis has been considered to be its main virulence 
mechanism (5, 20) by which this organism is able to persist in 
infections/diseases (11). Many implant infections sometimes
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requires the implant removal, causing considerable suffering 
for the patient, with pain and disability and even increased 
mortality (8, 9). Moreover, the long-term systemic antibiotics, 
surgical debridement, and prolonged hospitalization, greatly 
increase the costs associated with implant replacement surgery. 
The biofilm formation ability is a major clinical problem, 
mainly due to the intrinsic tolerance/resistance of biofilm cells 
to antibiotics (5). Antibiotic combination represents a 
therapeutic option in the treatment of S. epidermidis infections 
(14). However, increasing multiple resistance to antibiotics has 
made the development of new treatment options for serious 
infections a matter of urgent concern. In recent years, much 
research has been devoted to investigating possible alternatives 
to antibiotics, studying their mode of action and synergistic 
effects with other antimicrobial compounds. Farnesol is a 
sesquiterpene alcohol that has demonstrated to inhibit the 
growth of some microorganisms, such as Staphylococcus 
aureus and Streptococcus mutans, evidencing its potential use 
as antimicrobial agent (6, 11). The mechanism of action of this 
sesquiterpenoid probably involves cell membrane damages (6, 
11, 13). N-acetylcysteine is another non-antibiotic drug that has 
antibacterial properties (17). NAC is one of the smallest drug 
molecules in use and it is generally used in the medical 
treatment of chronic bronchitis, cancer and paracetamol 
intoxication (15). The prevention of biofilm formation and 
adherence to biomaterials devices is another possible role of 
NAC (17). 
Considering the results previously obtained with these 
compounds, the purpose of this work was to investigate the 
possible synergistic effect of farnesol with N-acetylcysteine 
against S. epidermidis planktonic and biofilm cells.  
 
MATERIALS AND METHODS 
 
Bacterial strains and culture conditions 
Two clinical isolates of S. epidermidis, known for their 
ability to form biofilms, were used in this work: strain 1457 
(isolated from an infected central venous catheter) and strain 
9142, a known producer of the polysaccharide intracellular 
adhesin (PIA). All strains were gently provided by Dr. G. B. 
Pier, Channing Laboratory, Department of Medicine, Brigham 
and Women’s Hospital, Harvard Medical School, Boston. Both 
strains were grown for 18 ± 2 h, at 37ºC and 120 rpm in 30 mL 
of Tryptic Soy Broth (TSB) (Merck, Darmstadt, Germany). 
Then the cells were centrifuged (9500 ×g, 5 min, 4ºC), washed 
twice with a saline solution [0.9% NaCl (Merck, Darmstadt, 
Germany) in distilled water] and sonicated (Ultrasonic 
Processor, Cole-Parmer Illinois, USA) (22% amplitude, 10s). 
The cellular suspensions were adjusted to a final concentration 
of approximately 1 × 109 cells mL-1, determined by optical 
density at 640 nm, prior to be used in the subsequent assays. 
 
Planktonic assays 
Viability assays were performed in 100 mL Erlenmeyers 
containing a S. epidermidis cell suspension (~ 2 × 108 cells mL-
1) in the presence of farnesol (300 M) (Sigma, St Louis, 
USA), NAC (NAC 1 × MIC = 4 mg mL-1 and 10 × MIC = 40 
mg mL-1) (Sigma, St Louis, USA) and farnesol-NAC.  It 
should be noted that 300 M farnesol was previously shown to 
be highly effective against planktonic cells of S. epidermidis 
(7). The suspensions were incubated for 24 hours, at 37ºC and 
at 130 rpm. Afterwards, cellular viability was assessed by 
colony forming units (CFU), while cell activity was determined 
by the XTT ({2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-
[(phenylamino)carbonyl]-2H-tetrazolium hydroxide}) (Sigma, 
St Louis, USA) reduction assay (12).  
CFU enumeration: CFU were obtained as follows: 1000 
L of each cellular suspension after being washed with 0.9% 
NaCl, were resuspended in 0.9% NaCl, followed by 20 s of 
sonication at 22 W to homogenize the suspension. This 
procedure disrupted the cell clumps without impairing cell 
viability (4). Viable cells were determined by performing 10-
fold serial dilutions in saline solution and plating in TSA 
(Merck, Darmstadt, Germany). Colonies were counted after 24 
 237 
Gomes, F. et al.                      S. epidermidis planktonic and biofilm cells 
 
 
h incubation at 37ºC. 
XTT assay: For XTT assay, aliquots of 200 L of each cell 
suspension were collected. The cells were washed with 0.9% NaCl 
by centrifugation for 10 min at 9500 ×g and 4ºC. The pellet was 
resuspended in 200 L of 0.9% NaCl and dispensed in a well of a 
microtiter plate. Then, 50 L of a solution containing 200 mg L-1 
of XTT and 20 mg L-1 of phenazine methosulphate (PMS) (Sigma, 
St Louis, USA) were added. The microtiter plates were incubated 
for 3 h at 37ºC in the dark. The absorbance was measured at 490 
nm. 
Controls included cells not exposed to farnesol or NAC 
(positive control) and also cells exposed either to farnesol or to 
NAC alone. All experiments were carried out in triplicate and 
repeated three times. 
 
Biofilm assays 
Biofilm formation and treatment: Biofilms were formed in 
96 well tissue culture plates containing 200 L of S. epidermidis 
cell suspension (1 × 106 cells mL-1) (1457 and 9142 strains) in 
TSB supplemented with 0.25% glucose (Merck, Darmstadt, 
Germany) per well to promote biofilm formation. Plates were 
incubated for 24 h at 37ºC on an orbital shaker (130 rpm). At the 
end, planktonic cells were removed carefully, and the biofilm was 
washed twice with 200 L of 0.9% NaCl. The biofilms were 
incubated in fresh nutrient medium containing farnesol (300 M), 
NAC (1 × MIC and 10 × MIC) and combination of both. XTT, 
CFU and crystal violet (CV) assays were performed after 24 hours 
of exposure to antimicrobial agents (alone and in combination) 
tested. At time 0 (before exposure to antimicrobial agents) the 
initial cellular concentration of biofilm (~ 2 × 108 cells mL-1) was 
determined.  
XTT assay: The quantification of biofilm cellular activity 
was assessed through the XTT reduction assay. After exposure to 
farnesol and NAC, biofilms were washed with 0.9% NaCl. Then, 
250 L of a solution containing 200 mg L-1 of XTT and 20 mg L-1 
of PMS were added to each well. The microtiter plates were 
incubated for 3 h at 37ºC in the dark. The absorbance was 
measured at 490 nm.  
CFU enumeration: CFU were obtained as follows: the 
planktonic cells were removed carefully and the biofilm was 
washed twice with 200 L of 0.9% NaCl. The wells were 
thoroughly scraped and ressuspended in 1 mL of 0.9% NaCl, 
followed by centrifugation for 10 min at 9500 ×g. The pellet was 
resuspended in 0.9% NaCl and washed twice, followed by 20 s of 
sonication at 22 W to homogenize the suspension. Viable cells 
were determined by performing 10-fold serial dilutions in saline 
solution and plating in TSA. Colonies were counted after 24 h 
incubation at 37ºC. 
Crystal Violet assay: CV was used as indicator of total 
biofilm biomass. For the measurement of this parameter, biofilms 
were washed with 250 L of 0.9% NaCl, then 250 L of methanol 
(Merck, Darmstadt, Germany) were added and left to act during 15 
minutes. Afterwards, methanol was removed and 250 L of crystal 
violet 1% (v/v) (Merck, Darmstadt, Germany) were added (5 min). 
The wells were washed with distilled water and finally, acetic acid 
33% (v/v) (Merck, Darmstadt, Germany) was added. The 
absorbance was measured at 570 nm. 
Controls were cells not exposed to farnesol or NAC (positive 
control), and cells exposed either to farnesol or NAC alone. All 
experiments were carried out in triplicate and repeated three times. 
 
Scanning Electron Microscopy (SEM) 
Biofilms were dehydrated by immersion in increasing ethanol 
(Merck, Darmstadt, Germany) concentration solutions: 70 (10 
min), 95 (10 min) and 100% (20 min) (v/v), having then been 
placed in a sealed desiccator. Samples were mounted on 
aluminium strubs with carbon tape, sputter coated with gold and 
observed with a Field Emission Gun – Scanning Electron 
Microscope (FEG/ESEM) - Nova Nano SEM 200  from FEI 
Company. 
Three fields were used for image analysis. All photographs 
were taken at a magnification of × 40 000. 
 
Statistical analysis 
The results from all assays were compared by the one-way 
analysis of variance by applying the Bonferroni and Tukey 
multiple comparison tests, using the SPSS (Statistical Package for 
the Social Sciences Inc, Chicago). All tests were performed with 
95% confidence level. 
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RESULTS 
 
Figure 1 presents the effect of farnesol, NAC and the 
association farnesol-NAC on Staphylococcus epidermidis 
planktonic cells. NAC at 1 × MIC concentration is less 
effective than farnesol at 300 M (p < 0.05) (Fig. 1). The 
combination of farnesol at 300 M with NAC at 1 × MIC 
caused a higher CFU log reduction when compared to each one 
alone (p < 0.05). This combination resulted into an additional 
log reduction of 0.5 and 1 for strains 1457 and 9142, 
respectively (p < 0.05) and relatively to the most effective of 
both antimicrobial agents tested, ie farnesol at 300 M. 
However, NAC at 10 × MIC was more effective than farnesol 
alone and farnesol and NAC 1 × MIC. After 24 hours, NAC 10 
× MIC caused 8 log reduction resulting in total cell death (Fig. 
1). 
 
 
 
Figure 1. Effect of farnesol and/or NAC on planktonic cells of S. epidermidis 1457 (a) and 9142 (b), after 24 hours of contact with farnesol (300 
M), NAC (4 mg mL-1 and 40 mg mL-1) and farnesol-NAC. Error bars represent standard deviation. Legend: 1- Positive control; 2- NAC 1 × 
MIC; 3- NAC 10 × MIC; 4- Farnesol 300 µM; 5- Farnesol 300 µM + NAC 1 × MIC; 6- Farnesol 300 µM + NAC 10 × MIC. 
 
 
Relatively to biofilm cells, although NAC 10 × MIC did not 
cause total cell death it was the most efficient against S. 
epidermidis biofilm cells causing a reduction of approximately 4 
log (Fig. 2). Conversely to planktonic cells, farnesol and NAC 1 × 
MIC had a similar effect in biofilms. For strain 1457, NAC 1 × 
MIC and farnesol worked better together than alone (p < 0.05) 
(Fig. 2a). There was no synergistic or additional effect when NAC 
10 × MIC was combined with farnesol at 300 M (p < 0.05). 
 
 
Figure 2. Effect of farnesol and/or NAC on biofilm cells of S. epidermidis 1457 (a) and 9142 (b), after 24 hours of contact with farnesol (300 
M), NAC (4 mg mL-1 and 40 mg mL-1) and farnesol-NAC. Error bars represent standard deviation. Legend: 1- Positive control; 2- NAC 1 × 
MIC; 3- NAC 10 × MIC; 4- Farnesol 300 µM; 5- Farnesol 300 µM + NAC 1 × MIC; 6- Farnesol 300 µM + NAC 10 × MIC. 
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The results of the XTT reduction assay, indicative of the 
metabolic activity of cells within the biofilm and CV staining 
assay, which allows the quantification of the total biofilm 
biomass, after a 24h treatment with farnesol, NAC, and 
farnesol+NAC are presented in table 1. These results 
confirmed the absence of synergy between farnesol and NAC. 
NAC at 10 × MIC was the antimicrobial agent treatment more 
efficient against both S. epidermidis strains tested, causing a 
significant decrease in the metabolic activity of biofilm cells 
and total biofilm biomass (p < 0.05). 
 
Table 1. Optical density (absorbance) and confidence interval obtained from XTT and Crystal Violet assays in biofilm cells of S. 
epidermidis after exposure to farnesol, NAC and farnesol/NAC combination. 
 S. epidermidis 1457 S. epidermidis 9142 
Condition XTT CV XTT CV 
Positive control 3.124 ± 0.151 2.735 ± 0.280 2.314 ± 0.099 2.807 ± 0.279 
NAC 1 × MIC 1.720 ± 0.149 2.649 ± 0.232 1.452 ± 0.078 2.577 ± 0.281 
NAC 10 × MIC 1.277 ± 0.173 1.931 ± 0.117 1.124 ± 0.156 1.817 ± 0.204 
Farnesol 300 µM 1.910 ± 0.185 2.763 ± 0.250 1.715 ± 0.097 2.260 ± 0.379 
Farnesol 300 µM + NAC 1 × MIC 1.928 ± 0.148 2.707 ± 0.241 1.498 ± 0.161 2.132 ± 0.386 
Farnesol 300 µM + NAC 10 × MIC 1.360 ± 0.106 1.868 ± 0.127 1.195 ± 0.169 1.681 ± 0.290 
 
 
Representative scanning electron microscopy images of 
1457 S. epidermidis biofilms after being exposed to farnesol, 
NAC and farnesol-NAC are presented on figure 3. These 
images specifically show the effect on the biofilm matrix and 
biofilm cell viability, and are in agreement with the results 
presented above. All biofilms treated with NAC revealed a 
desintegration of the matrix which is more noticeable for NAC 
at 40 mg mL-1 (10x MIC). Farnesol seems to have also an 
effect on biofilm matrix but not as pronounced as NAC.  
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Figure 3. Scanning electron micrographs of 24 h-biofilm of S. epidermidis 1457 after exposure to farnesol, NAC, and the 
combination of both for 24 h. (a) Positive control; (b) 300 µM farnesol; (c) NAC 1 × MIC; (d) NAC 10 × MIC; (e) Farnesol 300 
µM + NAC 1 × MIC; (f) Farnesol 300 µM + NAC 10 × MIC. Magnification × 40 000. 
 
 
DISCUSSION 
 
In this work, the effect of farnesol, NAC and farnesol-
NAC combination against S. epidermidis planktonic and 
biofilm cells was studied. For that, two good biofilm-forming 
strains were selected, strains 1457 and 9142 (19). Comparing 
these two strains, 1457 produces slightly more biofilm than 
9142 (19). The biofilm formation ability is due to the formation 
of PIA homopolymer, which surrounds and connects S. 
epidermidis cells in biofilm form (16). The extracellular matrix 
is extremely important for intercellular connection during 
surface colonization (10) and protection against the host 
immune system and resistance to antibiotics (1). Figure 3a 
represents a 48 hours biofilm of S. epidermidis 1457 and shows 
the thickness of biofilm and the presence of a noticeable 
amount of biofilm matrix.    
N-acetylcysteine (NAC), a potent antioxidant that reduces 
disulphide bonds linking mucin oligomers, has been widely 
used as a mucolytic agent for inhalation therapy in patients 
with chronic bronchitis. NAC has been shown not only to 
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reduce adhesion but also to detach bacterial cells adhered to 
surfaces and to inhibit bacterial growth in vitro (15). NAC 
decreases biofilm formation by a variety of bacteria and 
reduces the production of extracellular polysaccharide matrix, 
while promoting the disruption of mature biofilm (2).  
On the other hand, the principal interaction of farnesol 
appears to be with the cytoplasmatic membrane (11). Farnesol 
is a sesquiterpenoid that already demonstrated synergistic 
effect with another antimicrobial agent (gentamicin) indicating 
a potential application as an adjuvant therapeutic agent (11). 
According to previous studies, where farnesol was tested at 
concentrations ranging from 30 to 300 µM, the last 
concentration demonstrated to have an antimicrobial effect 
against S. epidermidis as well as against other bacteria (7, 11).  
We hypothesized that the combination of NAC with 
farnesol could be synergystic in the treatment of S. epidermidis 
infections as they both act on different components of the 
biofilm. Our results revealed that additionally to be bactericidal 
NAC seems also to act against the matrix. In fact, NAC seems 
to destroy the biofilm matrix resulting in the detachment of 
cells and thus the biofilm cells become more exposed and 
susceptible. This high effect against biofilm cells of S. 
epidermidis must be due in part to the small molecular size of 
NAC (Molecular Weight = 163.19), which easily penetrates 
into the biofilm. NAC at 1 × MIC in combination with 300 µM 
farnesol resulted in a higher antimicrobial effect against 
planktonic cells of S. epidermidis 1457 and 9142 than both 
antimicrobial agents alone. Nevertheless NAC alone at 10 x 
MIC, similarly to biofilms, showed a very high bactericidal 
effect. Although its very high effect on planktonic cells 
promoting CFU reductions above 8 log, it is probably more 
impressive its bactericidal effect on biofilms, which are always 
very tolerant to the most common antibiotics (7). However, 
unlike it was expected it did not work in synergy with farnesol 
at 300 µM against biofilm cells. 
Comparatively to planktonic cells, biofilm cells were 
much more tolerant to the inhibitory effect of farnesol, NAC 
and farnesol-NAC. As mentioned above, this fact must be due 
to the protective effect of the matrix. The effect of NAC was 
concentration dependent. While with NAC at 1 × MIC an 
average reduction of 2.5 log was observed, NAC 10 × MIC 
was enought to kill all planktonic cells. However, for biofilm 
cells this concentration (10 × MIC) only promoted an 
approximatly 4 log reduction in the number of viable cells 
within the biofilm, while only 1 log was attained with 1 × MIC. 
The peak serum concentration of NAC after a 600 mg oral 
dose was estimated to be 0.465 mg mL-1 (18). The 
concentrations of NAC tested in our study (1 × MIC and 10 × 
MIC, 4 and 40 mg mL-1) are rather higher than those reached in 
serum when applied by the intravenous or oral route. However, 
when applied locally it may be possible to obtain 
concentrations that prevent the formation of biofilms and 
consequently the adherence of S. epidermidis. (17).  
In another study, a concentration of 80 mg mL-1 of NAC 
was tested in vitro based on preliminary data that showed a 
dose-response relashionship on planktonic bacteria (2). Based 
in these results it seems to be feasible the use of 40 mg mL-1 in 
vivo. 
In conclusion, NAC at 40 mg mL-1 was the only of the 
tested treatments that was bactericidal against S. epidermidis 
cells both in planktonic or in biofilm form. Moreover, although 
NAC and farnesol have different modes of action, the 
combination of both has no significant synergistic effect.  
 
ACKNOWLEDGEMENTS 
 
Fernanda Gomes and Pilar Teixeira fully acknowledge the 
financial support of Fundação para a Ciência e Tecnologia 
(FCT) through the grants SFRH/BD/32126/2006 and 
SFRH/BPD/26803/2006, respectively. 
 
REFERENCES 
 
1. An, Y.; Friedman, R. (1997). Laboratory methods for studies of bacterial 
adhesion. J. Microbiol. Methods 30, 141-152. 
 242 
Gomes, F. et al.                      S. epidermidis planktonic and biofilm cells 
 
 
 
2. Aslam, S.; Trautner, B.W.; Ramanathan, V.; Darouiche, R. (2007). 
Combination of tigecycline and N-acetylcysteine reduces biofilm-
embedded bacteria on vascular catheters.  Antimicrob. Agents 
Chemother. 51, 1556-1558. 
3. Cargill, J.S.; Upton, M. (2009). Low concentration of vancomycin 
stimulate biofilm formation in some clinical isolates of Staphylococcus 
epidermidis. J. Clin. Pathol. 62, 1112-1116. 
4. Cerca, N.; Martins, S.; Cerca, F.; Jefferson, K.K.; Pier, G.B.; Oliveira, 
R.; Azeredo, J. (2005a). Comparative assessment of antibiotic 
susceptibility of coagulase-negative staphylococci in biofilm versus 
planktonic culture as assessed by bacterial enumeration or rapid XTT 
colorimetry. J. Antimicrob. Chemother. 56, 331-336. 
5. Cerca, N.; Martins, S.; Sillankorva, S.; Jefferson, K.K.; Pier, G.B.; 
Oliveira, R.; Azeredo, J. (2005b). Effects of growth in the presence of 
subinhibitory concentrations of dicloxacillin on Staphylococcus 
epidermidis and Staphylococcus haemolyticus biofilms. Appl. Environ. 
Microbiol. 71, 8677-8682. 
6. Derengowski, L.S.; De-Souza-Silva, C.; Braz, S.V.; Mello-De-Sousa, 
T.M.; Báo, S.N.; Kyaw, C.M.;  Silva-Pereira, I. (2009). Antimicrobial 
effect of farnesol, a Candida albicans quorum sensing molecule, on 
Paracoccidioides brasiliensis growth and morphogenesis. Ann. Clin. 
Microbiol. Antimicrob. 8, 13.  
7. Gomes, F.I.A.; Teixeira, P.; Azeredo, J.; Oliveira, R. (2009). Effect of 
farnesol on planktonic and biofilm cells of Staphylococcus epidermidis. 
Curr. Microbiol. 59, 118-122.  
8. Hajdu, S.; Lassnigg, A.; Graninger, W.; Hirschl, A.M.; Presterl, E. 
(2009). Effects of vancomycin, daptomycin, fosfomycin, tigecycline, and 
ceftriaxone on Staphylococcus epidermidis biofilms. J. Orthop. Res. 27, 
1361-1365. 
9. Hellmark, B.; Unemo, M.; Nilsdotter-Augustinsson, A.; Söderquist, B. 
(2009). Antibiotic susceptibility among Staphylococcus epidermidis 
isolated from prosthetic joint infections with special focus on rifampicin 
and variability of the rpoB gene. Clin. Microbiol. Infect. 15, 238-244. 
10. Hussain, M.; Hasting, J.G.M.; White, P.J. (1991). Isolation and 
composition of the extracellular slime made by coagulase staphylococci 
in a chemically defined medium. J. Infect. Dis. 163, 534-541. 
11. Jabra-Rizk, M.A.; Meiller, T.F.; James, C.E.; Shirtliff, M.E. (2006). 
Effect of farnesol on Staphylococcus aureus biofilm formation and 
antimicrobial susceptibility. Antimicrob. Agents Chemother. 50, 1463-
1469. 
12. Kuhn, D.M.; Balkis, M.; Chandra, J.; Mukherjee, P.K.; Ghannoum, M.A. 
(2003). Uses and limitations of the XTT assay in studies of Candida 
growth and metabolism. J. Clin. Microbiol. 41, 506-508. 
13. Kuroda, M.; Nagasaki, S.; Ohta, T. (2007). Sesquiterpene farnesol 
inhibits recycling of the C55 lipid carrier of the murein monomer 
precursor contributing to increased susceptibility to β-lactams in 
methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 
59, 425-432.  
14. Monzón, M.; Oteiza, C.; Leiva, J.; Amorena, B. (2001). Synergy of 
different antibiotic combinations in biofilms of Staphylococcus 
epidermidis. J. Antimicrob. Chemother. 48, 793-801. 
15. Olofsson, A.; Hermansson, M.; Elwing, H. (2003). N-acetyl-L-Cysteine 
affects growth, extracellular polysaccharide production, and bacterial 
biofilm formation on solid surfaces. Appl. Environ. Microbiol. 69, 4814-
4822. 
16. Otto, M. (2009). Staphylococcus epidermidis- the “accidental” pathogen. 
Microbiology 7, 555-567. 
17. Pérez-Giraldo, C.; Rodriguez-Benito, A.; Moran, F.J.; Hurtado, C.; 
Blanco, M.T.; Gomez-Garcia, A.C. (1997). Influence of N-acetylcysteine 
on the formation of biofilm by Staphylococcus epidermidis. J. 
Antimicrob. Chemother. 39, 643-646. 
18. Rehman, T.; Fought, J.; Solomon, R. (2008). N-acetylcysteine effect on 
serum creatinine and cystatin C levels in CKD Patients. Clin. J. Am. Soc. 
Nephrol. 3, 1610-1614. 
19. Sousa, C.; Teixeira, P.; Oliveira, R. (2009). The role of extracellular 
polymers on Staphylococcus epidermidis biofilm biomass and metabolic 
activity. J. Basic Microbiol. 49, 363-370. 
20. Vuong, C.; Kocianova, S.; Yao, Y.; Carmody, A.B.; Otto, M. (2004). 
Increased colonization of indwelling medical devices by quorum-sensing 
mutants of Staphylococcus epidermidis in vivo. J. Infect. Dis. 2004; 190, 
1498-1505.  
21. Wang, C.; Li, M.; Dong, D.; Wang, J.; Ren, J.; Otto, M.; Gao, Q. (2007). 
Role of ClpP in biofilm formation and virulence of Staphylococcus 
epidermidis. Microbes Infect 9, 1376-1383. 
22. Ziebuhr, W.; Hennig, S.; Eckart, M.; Kränzler, H.; Batzilla, C.; 
Kozitskaya, S. (2006). Nosocomial infections by Staphylococcus 
epidermidis: how a commensal bacterium turns into a pathogen. Int. J. 
Antimicrob. Agents 28, 14-20. 
All the content of the journal, except where otherwise noted, is licensed under a Creative Commons License 
 
 
 
